TSC22D3 and COVID-19: Our group was able to demonstrate that critically ill COVID-19 patients exhibit increased mRNA expression of both GCR-α and the GC-inducible gene, glucocorticoid-inducible leucine zipper (GILZ), as well as increased serum cortisol levels, compared to critically ill patients without COVID-19 but comparable disease severity.